Brief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
BRIEF-Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook Nov 5 - Medacta Group SA MOVE.S:
UPDATES GUIDANCE FOR 2026 AND REITERATES 2024-2027 MID-TERM OUTLOOK
EXPECTS FY2026 ADJUSTED EBITDA MARGIN BROADLY IN LINE WITH 2025 IN CONSTANT CURRENCY
EXPECTS FY2026 REVENUE GROWTH OF AROUND 9% IN CONSTANT CURRENCY
Source text: nEQ1fWtRCa
Further company coverage: MOVE.S:
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million